2024 |
Weickert, T. W., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W. S., . . . Shannon Weickert, C. (2024). Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial. Brain, Behavior, and Immunity, 115, 191-200. DOI Scopus3 Europe PMC2 |
2024 |
Weickert, T. W., Ji, E., Galletly, C., Boerrigter, D., Morishima, Y., Bruggemann, J., . . . Kindler, J. (2024). Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning. Schizophrenia Bulletin, 50(2), 403-417. DOI Scopus1 Europe PMC1 |
2024 |
Tran, L., Hahn, L., Gill, S., Ng, F., Clarke, P., Paterson, T., & Galletly, C. (2024). Do benzodiazepines reduce the efficacy of transcranial magnetic stimulation?. Australasian Psychiatry, 32(3), 180-185. DOI |
2024 |
Galletly, C. (2024). Antipsychotic augmentation of clozapine. Australasian Psychiatry, 1 page. DOI |
2024 |
Galbally, M., Kotze, B., Bell, C., Quadrio, C., Galletly, C., Herrman, H., . . . Morgan, S. (2024). Achieving gender equity in academic psychiatry – barriers to involvement and solutions for success. Australasian Psychiatry. DOI |
2024 |
Christodoulou, V., Liu, D., Esterman, A., & Galletly, C. (2024). ‘Facilitators and barriers to recruitment in mental health research: A survey of psychiatrists and psychiatry registrars in training’. Australasian Psychiatry, 10398562241288424. DOI |
2023 |
Arnautovska, U., Vitangcol, K., Kesby, J. P., Warren, N., Rossell, S. L., Neill, E., . . . Siskind, D. (2023). Verbal and visual learning ability in patients with treatment-resistant schizophrenia: A 1-year follow-up study. Schizophrenia Research: Cognition, 33, 100283. DOI Scopus1 |
2023 |
Lindell‐Innes, R., Phillips‐Hughes, A. L., Bartsch, D., Galletly, C., & Ludbrook, C. (2023). Attitudes of psychiatry trainees towards patients with borderline personality disorder: Does the stigma begin during training?. Personality and Mental Health, 17(4), 387-395. DOI Scopus4 Europe PMC1 |
2022 |
Thomson, S., Galletly, C., Prener, C., Garverich, S., Liu, D., & Lincoln, A. (2022). Associations between health literacy, cognitive function and general literacy in people with schizophrenia attending community mental health clinics in Australia.. BMC Psychiatry, 22(1), 9 pages. DOI Scopus3 Europe PMC2 |
2022 |
Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., . . . Gershon, E. S. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508. DOI Scopus970 WoS534 Europe PMC777 |
2022 |
Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hahn, L., Lavale, A., . . . Fitzgerald, P. B. (2022). Does switching between high frequency rTMS and theta burst stimulation improve depression outcomes?. Brain Stimulation, 15(4), 889-891. DOI Scopus2 WoS1 Europe PMC1 |
2022 |
Sigrist, C., Vöckel, J., MacMaster, F. P., Farzan, F., Croarkin, P. E., Galletly, C., . . . Koenig, J. (2022). Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies. European Child and Adolescent Psychiatry, 31(10), 1501-1525. DOI Scopus22 Europe PMC10 |
2022 |
Neill, E., Rossell, S. L., Yolland, C., Meyer, D., Galletly, C., Harris, A., . . . Castle, D. J. (2022). N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms. Schizophrenia bulletin, 48(6), 1263-1272. DOI Scopus15 WoS4 Europe PMC8 |
2022 |
Condon, J., Stewart, C., & Galletly, C. (2022). Is PTSD a Bodily Injury?. Journal of law and medicine, 29(3), 888-894. |
2022 |
Nguyen, H., Haeney, O., & Galletly, C. (2022). The characteristics of older homicide offenders: a systematic review. Psychiatry, Psychology and Law, 29(3), 413-430. DOI Scopus3 |
2022 |
Ji, E., Boerrigter, D., Cai, H. Q., Lloyd, D., Bruggemann, J., O'Donnell, M., . . . Shannon Weickert, C. (2022). Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain, Behavior, and Immunity, 101, 423-434. DOI Scopus23 WoS12 Europe PMC16 |
2022 |
Amir Izzat, J., Cherrie, G., & Nick, F. (2022). Improving services for those who serve: A private practice initiative to improve psychiatric care for first responder and military patients. Australasian Psychiatry, 30(3), 103985622110578. DOI |
2022 |
Fitzgerald, P. B., Gill, S., Breakspear, M., Kulkarni, J., Chen, L., Pridmore, S., . . . Hoy, K. E. (2022). Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again. Australian & New Zealand Journal of Psychiatry, 56(8), 905-909. DOI Scopus6 WoS5 Europe PMC2 |
2022 |
Lam, N. S. K., Long, X. X., Li, X., Saad, M., Lim, F., Doery, J. C., . . . Galletly, C. (2022). The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review. Biomedicine and Pharmacotherapy, 146, 18 pages. DOI Scopus23 WoS10 Europe PMC8 |
2022 |
Murphy, C. E., Walker, A. K., O’Donnell, M., Galletly, C., Lloyd, A. R., Liu, D., . . . Weickert, T. W. (2022). Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Translational Psychiatry, 12(1), 11 pages. DOI Scopus16 WoS5 Europe PMC8 |
2022 |
Galletly, C. A. (2022). Effective family interventions for people with schizophrenia. The Lancet Psychiatry, 9(3), 185-187. DOI Scopus3 WoS1 Europe PMC2 |
2021 |
Giam, A., Chen, L., Lisa Hahn., Gill, S., Clarke, P., Ng, F., . . . Fitzgerald, P. (2021). Comparing theta burst stimulation with standard left high frequency transcranial magnetic stimulation in the treatment of depression in a randomized controlled study: A preliminary comparison study. Journal of Affective Disorders Reports, 5, 100162-1-100162-7. DOI Scopus5 |
2021 |
Arnautovska, U., Neill, E., Rossell, S. L., Yolland, C., Galletly, C., Harris, A., . . . Siskind, D. (2021). Does the clozapine/norclozapine ratio predict cognitive performance in patients with clozapine-resistant schizophrenia?. Australian and New Zealand Journal of Psychiatry, 56(7), 875-878. DOI Scopus3 Europe PMC2 |
2021 |
Ford, H., Hahn, L., Clarke, P., Gill, S., Carnell, B., & Galletly, C. (2021). A comparison of 15 minute vs 30 minute repetitive transcranial magnetic stimulation sessions for treatment resistant depression – are longer treatment sessions more effective?. Journal of Affective Disorders, 282, 974-978. DOI Scopus1 Europe PMC1 |
2021 |
Galletly, C., Suetani, S., Hahn, L., McKellar, D., & Castle, D. (2021). Ageing with psychosis – Fifty and beyond. Australian & New Zealand Journal of Psychiatry, 56(1), 39-49. DOI Scopus2 WoS1 Europe PMC1 |
2021 |
Bampton, T. J., Hack, D., & Galletly, C. A. (2021). Clozapine treatment for Huntington's disease psychosis.. The Australian and New Zealand journal of psychiatry, 56(2), 48674211013082. DOI Scopus4 Europe PMC2 |
2021 |
Enticott, P. G., Barlow, K., Guastella, A. J., Licari, M. K., Rogasch, N. C., Middeldorp, C. M., . . . Fitzgerald, P. B. (2021). Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trial. BMJ Open, 11(7), e046830-1-e046830-9. DOI Scopus12 WoS6 Europe PMC7 |
2021 |
Sharmil, H., Kelly, J., Bowden, M., Galletly, C., Cairney, I., Wilson, C., . . . de Crespigny, C. (2021). Participatory Action Research-Dadirri-Ganma, using Yarning: methodology co-design with Aboriginal community members. International Journal for Equity in Health, 20(1), 160-1-160-11. DOI Scopus30 WoS13 Europe PMC12 |
2021 |
Chen, L., Thomas, E. H., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., . . . Fitzgerald, P. B. (2021). Accelerated theta burst stimulation for the treatment of depression: a randomised controlled trial. Brain Stimul, 14(5), 1095-1105. DOI Scopus41 WoS23 Europe PMC16 |
2021 |
Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., . . . Fitzgerald, P. B. (2021). Corrigendum to, 'Accelerated theta burst stimulation for the treatment of depression: A randomised controlled trial' [Brain Stimulat. 14(5) (2021) 1095-1105].. Brain stimulation, 14(5), 1218. DOI |
2021 |
Jernbom Falk, A., Galletly, C., Just, D., Toben, C., Baune, B. T., Clark, S. R., . . . Schubert, K. O. (2021). Autoantibody profiles associated with clinical features in psychotic disorders. Translational Psychiatry, 11(1), 1-9. DOI Scopus11 WoS7 Europe PMC6 |
2020 |
Galletly, C., Ash, D., Sweeney, S., O'Neill, F., & Crichton, J. (2020). Identifying and exploring linguistic expertise of psychiatrists in interviews with patients with thought disorder.. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 28(2), 193-198. DOI |
2020 |
Ji, E., Weickert, C. S., Purves-Tyson, T., White, C., Handelsman, D. J., Desai, R., . . . Weickert, T. W. (2020). Cortisol-dehydroepiandrosterone ratios are inversely associated with hippocampal and prefrontal brain volume in schizophrenia. Psychoneuroendocrinology, 123, 104916. DOI Scopus8 WoS4 Europe PMC7 |
2020 |
Galletly, C. (2020). A Whale of an issue.. Aust N Z J Psychiatry, 54(11), 1053-1055. DOI |
2020 |
Yolland, C. O. B., Phillipou, A., Castle, D. J., Neill, E., Hughes, M. E., Galletly, C., . . . Rossell, S. L. (2020). Improvement of cognitive function in schizophrenia with N-acetylcysteine: a theoretical review. Nutritional Neuroscience, 23(2), 139-148. DOI Scopus30 Europe PMC19 |
2020 |
Cai, H. Q., Catts, V. S., Webster, M. J., Galletly, C., Liu, D., O Donnell, M., . . . Weickert, C. S. (2020). Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Molecular Psychiatry, 25(4), 761-775. DOI Scopus155 WoS127 Europe PMC99 |
2020 |
Wong, K. T. G., Liu, D., Balzan, R., King, D., & Galletly, C. (2020). Smartphone and Internet Access and Utilization by People With Schizophrenia in South Australia: Quantitative Survey Study.. JMIR mental health, 7(1), e11551. DOI Scopus15 WoS9 Europe PMC8 |
2020 |
Zulfic, Z., Weickert, C. S., Weickert, T. W., Liu, D., Myles, N., & Galletly, C. (2020). Neutrophil-lymphocyte ratio - a simple, accessible measure of inflammation, morbidity and prognosis in psychiatric disorders?. Australas Psychiatry, 28(4), 454-458. DOI Scopus24 WoS17 Europe PMC15 |
2020 |
Myles, H., Myles, N., Vincent, A. D., Wittert, G., Adams, R., Chandratilleke, M., . . . Galletly, C. (2020). Pilot cohort study of obstructive sleep apnoea in community-dwelling people with schizophrenia.. Ir J Psychol Med, 38(1), 1-7. DOI Scopus2 WoS2 Europe PMC2 |
2020 |
Galletly, C. (2020). Psychiatry in the COVID-19 Era. Australian and New Zealand Journal of Psychiatry, 54(5), 447-448. DOI Scopus21 Europe PMC14 |
2020 |
Siskind, D., Northwood, K., Berk, M., Castle, D., Galletly, C., & Harris, A. (2020). Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic. Australian and New Zealand Journal of Psychiatry, 54(7), 759-761. DOI Scopus2 Europe PMC1 |
2020 |
Cai, H. Q., Weickert, T. W., Catts, V. S., Balzan, R., Galletly, C., Liu, D., . . . Shannon Weickert, C. (2020). Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls. Brain, Behavior, and Immunity, 89, 200-208. DOI Scopus16 WoS5 Europe PMC8 |
2020 |
Clifford, L., Crabb, S., Turnbull, D., Hahn, L., & Galletly, C. (2020). A qualitative study of medication adherence amongst people with schizophrenia. Archives of Psychiatric Nursing, 34(4), 194-199. DOI Scopus13 WoS7 Europe PMC8 |
2020 |
Plevin, D., & Galletly, C. (2020). The neuropsychiatric effects of vitamin C deficiency: a systematic review.. BMC Psychiatry, 20(1), 1-9. DOI Scopus61 WoS35 Europe PMC34 |
2020 |
Thomson, S., Doan, T., Liu, D., Schubert, K. O., Toh, J., Boyd, M. A., & Galletly, C. (2020). Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic. Australasian Psychiatry, 28(5), 492-499. DOI Scopus14 WoS13 Europe PMC9 |
2020 |
Galletly, C. (2020). Sexual misconduct by doctors: a problem that has not gone away. Medical Journal of Australia, 213(5), 216-217. DOI Scopus2 WoS3 |
2020 |
Henderson, S., Berk, M., Boyce, P., Jorm, A., Galletly, C., Porter, R., . . . Malhi, G. (2020). Finding reviewers: A crisis for journals and their authors. Australian and New Zealand Journal of Psychiatry, 54(10), 957-959. DOI Scopus5 WoS2 |
2019 |
Balzan, R. P., Mattiske, J. K., Delfabbro, P., Liu, D., & Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A Randomized Clinical Trial.. Schizophrenia bulletin, 45(1), 27-36. DOI Scopus21 WoS15 Europe PMC9 |
2019 |
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., . . . Stubbs, B. (2019). The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. The Lancet Psychiatry, 6(8), 675-712. DOI Scopus899 WoS698 Europe PMC476 |
2019 |
Firth, J., Rosenbaum, S., Galletly, C., Siddiqi, N., Stubbs, B., Killackey, E., . . . Siskind, D. (2019). Protecting physical health in people with mental illness – Authors' reply. The Lancet Psychiatry, 6(11), 890-891. DOI Scopus17 WoS4 Europe PMC4 |
2019 |
Galletly, C. (2019). More access for some but not others: Is it better?. Australian and New Zealand Journal of Psychiatry, 53(11), 1041-1043. DOI Scopus1 |
2019 |
Szabo, S., Lloyd, B., McKellar, D., Myles, H., Newton, H., Schutz, J., . . . Galletly, C. (2019). ‘Having a mentor helped me with difficult times’: a trainee-run mentoring project. Australasian Psychiatry, 27(3), 230-233. DOI Scopus7 WoS3 Europe PMC4 |
2019 |
Galletly, C. A., & Xinhui, L. (2019). To suit the occasion, I wore my fancy dress.. Australasian Psychiatry. |
2019 |
Szabo, S., Lloyd, B., McKellar, D., Newton, H., Shutz, J., Hahn, L., & Galletly, C. (2019). 'Having a mentor helped me with difficult times:' a trainee-run mentoring project.. Australasian Psychiatry, 27(3), 230-233. |
2019 |
Balzan, R., Delfabbro, P., Mattiske, J., Liu, D., & Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A randomised Clinical Trial.. Schizophrenia Bulletin, 45(1), 27-36. |
2019 |
Galletly, C. (2019). Paracetamol, pregnancy and public health. Australian and New Zealand Journal of Psychiatry, 53(3), 181-183. DOI |
2019 |
Myles, N., Myles, H., Xia, S., Large, M., Bird, R., Galletly, C., . . . Siskind, D. (2019). A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia. Australian and New Zealand Journal of Psychiatry, 53(5), 403-412. DOI Scopus53 WoS33 Europe PMC20 |
2019 |
Lim, X., & Galletly, C. (2019). “To suit the occasion, I wore my schizophrenic fancy dress” – the life of Janet Frame. Australasian Psychiatry, 27(5), 1039856219839489. DOI Scopus2 WoS1 |
2019 |
Clarke, E., Clarke, P., Gill, S., Paterson, T., Hahn, L., & Galletly, C. (2019). Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders.. Journal of affective disorders, 252, 435-439. DOI Scopus41 WoS26 Europe PMC14 |
2019 |
Owens, S. J., Weickert, T. W., Purves-Tyson, T. D., Ji, E., White, C., Galletly, C., . . . Shannon Weickert, C. (2019). Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia.. Molecular neuropsychiatry, 5(1), 28-41. DOI Europe PMC2 |
2019 |
Weickert, C. S., Lee, C. H., Lenroot, R. K., Bruggemann, J., Galletly, C., Liu, D., . . . Weickert, T. W. (2019). Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia. Schizophrenia Research, 209, 212-217. DOI Scopus10 WoS9 Europe PMC4 |
2019 |
Lee, C. H., Sinclair, D., O'Donnell, M., Galletly, C., Liu, D., Weickert, C. S., & Weickert, T. W. (2019). Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Schizophrenia Research, 213, 87-95. DOI Scopus14 WoS13 Europe PMC6 |
2019 |
Kindler, J., Lim, C. K., Weickert, C. S., Boerrigter, D., Galletly, C., Liu, D., . . . Weickert, T. W. (2019). Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 43(11), 13 pages. DOI Scopus170 WoS129 Europe PMC102 |
2019 |
Turner, S., Harvey, C., Hayes, L., Castle, D., Galletly, C., Sweeney, S., . . . Spittal, M. J. (2019). Childhood adversity and clinical and psychosocial outcomes in psychosis. Epidemiology and Psychiatric Sciences, 29, e78. DOI Scopus39 Europe PMC23 |
2019 |
Myles, H., Myles, N., Coetzer, C. L. C., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2019). Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea: a pilot study. Schizophrenia Research: Cognition, 15, 14-20. DOI Scopus13 WoS9 Europe PMC4 |
2018 |
Hahn, L., Mackinnon, A., Foley, D., Morgan, V., Waterreus, A., Watts, G., . . . Galletly, C. (2018). Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis?. Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders, 12(6), 1045-1051. DOI Scopus7 WoS6 Europe PMC4 |
2018 |
Wong, K. T. G., Liu, D., Balzan, R., King, D., & Galletly, C. (2018). Smartphone and Internet Access and Utilization by People With Schizophrenia in South Australia: Quantitative Survey Study (Preprint). DOI |
2018 |
Galletly, C., & Myles, H. (2018). Making an impact. Australian and New Zealand Journal of Psychiatry, 52(8), 725-726. DOI Scopus1 Europe PMC1 |
2018 |
Jacomb, I., Stanton, C., Vasudevan, R., Powell, H., O'Donnell, M., Lenroot, R., . . . Weickert, T. (2018). C-Reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Frontiers in Immunology, 9(OCT), 2230-1-2230-16. DOI Scopus75 WoS60 Europe PMC47 |
2018 |
Rosenich, E., Gill, S., Clarke, P., Paterson, T., Hahn, L., & Galletly, C. (2018). Does rTMS reduce depressive symptoms in young people who have not responded to antidepressants?. Early Intervention in Psychiatry, 13(5), 1-7. DOI Scopus15 WoS8 Europe PMC5 |
2018 |
Galletly, C., Suetani, S., & Dark, F. (2018). Medication discontinuation in first episode psychosis: thinking about the offset of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 52(9), 819-821. DOI Scopus2 WoS2 |
2018 |
Myles, H., Vincent, A., Myles, N., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2018). Obstructive sleep apnoea is more prevalent in men with schizophrenia compared to general population controls: results of a matched cohort study. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 26(6), 600-603. DOI Scopus10 WoS5 Europe PMC1 |
2018 |
Myles, N., Myles, H., Xia, S., Large, M., Kisely, S., Galletly, C., . . . Siskind, D. (2018). Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta psychiatrica Scandinavica, 138(2), 101-109. DOI Scopus141 Europe PMC67 |
2018 |
Haeney, O., Ash, D., & Galletly, C. (2018). School Shootings – ‘It wouldn’t happen here’?. Australian and New Zealand Journal of Psychiatry, 52(5), 405-407. DOI Scopus1 WoS1 Europe PMC1 |
2018 |
Balzan, R. P., Dhillon, V. S., Liu, D., Hahn, L., Fenech, M. F., & Galletly, C. (2018). Shorter telomere length in people with schizophrenia who live alone?. Schizophrenia Research, 199, 422-423. DOI Scopus5 WoS3 Europe PMC3 |
2018 |
Campbell, L., Hanlon, M. -C., Galletly, C., Harvey, C., Stain, H., Cohen, M., . . . Brown, S. (2018). Severity of illness and adaptive functioning predict quality of care of children among parents with psychosis: A confirmatory factor analysis. Australian and New Zealand Journal of Psychiatry, 52(5), 435-445. DOI Scopus21 WoS18 Europe PMC15 |
2018 |
Koblar, S., Cranwell, M., Koblar, S., Carnell, B., & Galletly, C. (2018). Developing empathy: does experience through simulation improve medical student empathy?. Medical Science Educator, 28(1), 31-36. DOI Scopus10 |
2017 |
Boerrigter, D., Weickert, T., Lenroot, R., O'Donnell, M., Galletly, C., Liu, D., . . . Weickert, C. (2017). Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. Journal of Neuroinflammation, 14(1), 188-1-188-15. DOI Scopus124 WoS101 Europe PMC70 |
2017 |
Galletly, C. A. (2017). Psychiatry training: survive and thrive. The Medical journal of Australia, 206(11), 485. DOI |
2017 |
Galletly, C. (2017). Risks, benefits and finding the best way forward. Australian and New Zealand Journal of Psychiatry, 51(10), 963-964. DOI |
2017 |
Castle, D. J., Galletly, C. A., Dark, F., Humberstone, V., Morgan, V. A., Killackey, E., . . . Jablensky, A. (2017). The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders. Medical Journal of Australia, 206(11), 501-505. DOI Scopus20 WoS18 Europe PMC12 |
2017 |
Glass, L., Sinclair, D., Boerrigter, D., Naude, K., Fung, S., Brown, D., . . . Shannon Weickert, C. (2017). Brain antibodies in the cortex and blood of people with schizophrenia and controls. Translational Psychiatry, 7(8), 1-9. DOI Scopus15 Europe PMC13 |
2017 |
Jablensky, A., Castle, D. J., Dark, F., Humberstone, V., Killackey, E., Kulkarni, J., . . . Galletly, C. (2017). The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders – what’s next?. Australasian Psychiatry, 25(6), 600-602. DOI Scopus6 WoS6 Europe PMC6 |
2017 |
Groenkjaer, M., de Crespigny, C., Liu, D., Moss, J., Cairney, I., Lee, D., . . . Galletly, C. (2017). "The chicken or the egg": barriers and facilitators to collaborative care for people with comorbidity in a metropolitan region of South Australia. Issues in Mental Health Nursing, 38(1), 18-24. DOI Scopus11 WoS7 Europe PMC5 |
2017 |
Galletly, C. A., Carnell, B. L., Clarke, P., & Gill, S. (2017). A comparison of right unilateral and sequential bilateral repetitive transcranial magnetic stimulation for major depression: a naturalistic clinical Australian study. Journal of ECT, 33(1), 58-62. DOI Scopus9 WoS8 Europe PMC3 |
2017 |
Myles, N., Large, M., Myles, H., Adams, R., Liu, D., & Galletly, C. (2017). Australia's economic transition, unemployment, suicide and mental health needs. Australian and New Zealand Journal of Psychiatry, 51(2), 119-123. DOI Scopus12 WoS9 Europe PMC9 |
2017 |
Allison, S., Bastiampillai, T., Galletly, C., & Nance, M. (2017). An Australian collaborative research network: Building the evidence for inpatient psychiatry.. Australian and New Zealand Journal of Psychiatry, 51(8), 1. DOI |
2017 |
Galletly, C. (2017). Premature death in schizophrenia: bridging the gap. The Lancet Psychiatry, 4(4), 263-265. DOI Scopus20 WoS18 Europe PMC10 |
2017 |
Hahn, L. A., Mackinnon, A., Foley, D. L., Morgan, V. A., Waterreus, A., Watts, G. F., . . . Galletly, C. A. (2017). The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis. Schizophrenia Research, 184, 88-95. DOI Scopus2 WoS2 |
2017 |
Morgan, V., Waterreus, A., Carr, V., Castle, D., Cohen, M., Harvey, C., . . . Galletly, C. (2017). Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 51(2), 124-140. DOI Scopus87 WoS70 Europe PMC39 |
2017 |
Smith, C., Myles, H., & Galletly, C. (2017). Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk. Australasian Psychiatry, 25(4), 387-390. DOI Scopus4 WoS4 Europe PMC1 |
2017 |
Carnell, B. L., Clarke P., Gill, S., Galletly, C. A., & Galletly, C. A. (2017). How effective is repetitive Transcranial Magnetic Stimulation for Bipolar Depression?. The Journal of Affective Disorders, 209, 270-272. DOI Scopus16 WoS14 Europe PMC6 |
2017 |
Galletly, C., Dhillon, V. S., Liu, D., Balzan, R. P., Hahn, L. A., & Fenech, M. F. (2017). Shorter telomere length in people with schizophrenia: a preliminary study from Australia. Schizophrenia Research, 190, 46-51. DOI Scopus17 WoS14 Europe PMC10 |
2017 |
Posselt, M., McDonald, K., Procter, N., De Crespigny, C., & Galletly, C. (2017). Improving the provision of services to young people from refugee backgrounds with comorbid mental health and substance use problems: addressing the barriers. BMC Public Health, 17(1), 280-1-280-17. DOI Scopus40 WoS29 Europe PMC20 |
2017 |
Large, M., Galletly, C., Myles, N., Ryan, C. J., & Myles, H. (2017). Known unknowns and unknown unknowns in suicide risk assessment: Evidence from meta-analyses of aleatory and epistemic uncertainty. BJPsych Bulletin, 41(3), 160-163. DOI Scopus31 Europe PMC10 |
2017 |
Nielssen, O., McGorry, P., Castle, D., & Galletly, C. (2017). The RANZCP guidelines for Schizophrenia: why is our practice so far short of our recommendations, and what can we do about it?. Australian and New Zealand Journal of Psychiatry, 51(7), 670-674. DOI Scopus7 WoS5 Europe PMC4 |
2017 |
Siskind, D., Harris, M., Phillipou, A., Morgan, V., Waterreus, A., Galletly, C., . . . Castle, D. (2017). Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis. Epidemiology and psychiatric sciences, 26(3), 325-337. DOI Scopus23 WoS16 Europe PMC9 |
2017 |
Hahn, L., Mackinnon, A., Foley, D., Morgan, V., Waterreus, A., Watts, G., . . . Galletly, C. (2017). The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis. Schizophrenia Research, 182, 13-18. DOI Scopus3 WoS3 Europe PMC1 |
2017 |
Kulkarni, J., & Galletly, C. A. (2017). Improving safety for women in psychiatry wards. Australian and New Zealand Journal of Psychiatry, 51(2), 192-194. DOI Scopus8 WoS5 Europe PMC6 |
2017 |
Myles, H., Myles, N., Liu, D., Adams, R., Wittert, G., Antic, N. A., & Galletly, C. (2017). How long will we sleep on obstructive sleep apnoea in schizophrenia?. Australian & New Zealand Journal of Psychiatry, 51(1), 95-96. DOI Scopus3 WoS3 Europe PMC2 |
2016 |
Large, M., Galletly, C. A., Myles, N., Ryan, C. J., & Myles, H. (2016). Known unknown and unknown unknowns in Suicide Risk Assessment: Aleatory and Epistemic uncertainty. BJPsych Bulletin. |
2016 |
Weinberg, D., Lenroot, R., Jacomb, I., Allen, K., Bruggemann, J., Wells, R., . . . Weickert, T. (2016). Cognitive subtypes in schizophrenia characterized by differential brain volumetric reductions and cognitive decline. JAMA Psychiatry, 73(12), 1251-1259. DOI Scopus74 WoS65 Europe PMC49 |
2016 |
Liu, D., Myles, H., Foley, D., Watts, G., Morgan, V., Castle, D., . . . Galletly, C. (2016). Risk factors for obstructive sleep apnea are prevalent in people with psychosis and correlate with impaired social functioning and poor physical health. Frontiers in Psychiatry, 7(AUG), 139-1-139-12. DOI Scopus16 WoS12 Europe PMC7 |
2016 |
Morgan, V., Morgan, F., Galletly, C., Valuri, G., Shah, S., & Jablensky, A. (2016). Sociodemographic, clinical and childhood correlates of adult violent victimisation in a large, national survey sample of people with psychotic disorders. Social Psychiatry and Psychiatric Epidemiology, 51(2), 269-279. DOI Scopus22 WoS17 Europe PMC19 |
2016 |
Myles, H., Myles, N., Antic, N., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2016). Obstructive sleep apnea and schizophrenia: a systematic review to inform clinical practice. Schizophrenia Research, 170(1), 222-225. DOI Scopus51 WoS38 Europe PMC27 |
2016 |
Galletly, C., Clark, L., McFarlane, A., Searle, A., Sawyer, M., Sim, M., . . . van Hooff, M. (2016). Childhood lead exposure, childhood trauma, substance use and subclinical psychotic experiences - a longitudinal cohort study. Psychiatry Research, 239, 54-61. DOI Scopus5 WoS3 |
2016 |
Galletly, C., Turnbull, C., & Goldney, R. (2016). Medical student teaching in the private sector - An overlooked opportunity?. Australasian Psychiatry, 24(2), 198-200. DOI Scopus4 WoS3 Europe PMC2 |
2016 |
Galletly, C. A., Gill, S., Rigby, A., Carnell, B. L., & Clarke, P. (2016). Assessing the effects of repetitive transcranial magnetic stimulation on cognition in major depressive disorder using computerized cognitive testing. Journal of ECT, 32(3), 169-173. DOI Scopus11 WoS9 Europe PMC6 |
2016 |
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., . . . Tran, N. (2016). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 50(5), 410-472. DOI Scopus614 WoS489 Europe PMC317 |
2016 |
Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2016). Awareness of pre-diabetes or diabetes and associated factors in people with psychosis. Schizophrenia Bulletin, 42(5), 1280-1289. DOI Scopus12 WoS10 Europe PMC4 |
2016 |
Liu, D., de Crespigny, C., Procter, N., Kelly, J., Francis, H., Posselt, M., . . . Galletly, C. A. (2016). Comorbidity action in the north – a study of services for people with comorbid mental health and drug and alcohol disorders in the northern suburbs of Adelaide. Australasian Psychiatry, 24(6), 592-597. DOI Scopus10 WoS9 Europe PMC7 |
2016 |
Suetani, S., Waterreus, A., Morgan, V., Foley, D., Galletly, C., Badcock, J., . . . McGrath, J. (2016). Correlates of physical activity in people living with psychotic illness. Acta Psychiatrica Scandinavica, 134(2), 129-137. DOI Scopus41 WoS37 Europe PMC21 |
2016 |
Cohen, O., Weickert, T., Hess, J., Paish, L., McCoy, S., Rothmond, D., . . . Glatt, S. (2016). A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Molecular Psychiatry, 21(7), 975-982. DOI Scopus25 WoS17 Europe PMC18 |
2016 |
Galletly, C. (2016). Compulsive reading: Stars with addictions, to Star Wars. Australian and New Zealand Journal of Psychiatry, 50(8), 713-715. DOI |
2016 |
Waterreus, A., Di Prinzio, P., Watts, G., Castle, D., Galletly, C., & Morgan, V. (2016). Metabolic syndrome in people with a psychotic illness: Is cannabis protective?. Psychological Medicine, 46(8), 1651-1662. DOI Scopus18 Europe PMC10 |
2016 |
Foley, D., Mackinnon, A., Morgan, V., Castle, D., Waterreus, A., Galletly, C., & Galletly, C. (2016). Comorbid Diabetes and Depression in a National Sample of Adults With Psychosis. Schizophrenia Bulletin, 44(1), 9 pages. DOI Scopus11 WoS6 Europe PMC6 |
2016 |
Sweeney, S., Air, T., Zannettino, L., Shah, S. S., & Galletly, C. (2016). Corrigendum: Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis [Front. Psychol, 6, (2015):(1768)] Doi: 10.3389/fpsyg.2015.01768. Frontiers in Psychology, 7(AUG), 2 pages. DOI Scopus1 WoS1 Europe PMC1 |
2016 |
Rossell, S., Francis, P., Galletly, C., Harris, A., Siskind, D., Berk, M., . . . Castle, D. (2016). N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry, 16(1), 320-1-320-9. DOI Scopus30 WoS24 Europe PMC15 |
2016 |
Large, M., Galletly, C., Myles, N., Ryan, C., & Myles, H. (2016). Known unknown and unknown unknowns in suicide risk assessment: what do recent meta-analyses tell us about aleatory and epistemic uncertainty?. BJ Psych Bulletin, 1-4. |
2016 |
Galletly, C. A. (2016). Look who's talking. Aust N Z J Psychiatry, 50(11), 1031-1032. DOI |
2016 |
Pillai, A., Howell, K., Ahmed, A., Weinberg, D., Allen, K., Bruggemann, J., . . . Weickert, T. (2016). Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 21(5), 686-692. DOI Scopus62 WoS50 Europe PMC36 |
2016 |
Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2016). Common familial risk factors for schizophrenia and diabetes mellitus. Australian and New Zealand Journal of Psychiatry, 50(5), 488-494. DOI Scopus23 WoS17 Europe PMC11 |
2015 |
Happell, B., Galletly, C., Castle, D., Platania-Phung, C., Stanton, R., Scott, D., . . . Furness, T. (2015). Scoping review of research in Australia on the co-occurrence of physical and serious mental illness and integrated care. International Journal of Mental Health Nursing, 24(5), 421-438. DOI Scopus14 WoS15 Europe PMC8 |
2015 |
Balzan, R., & Galletly, C. (2015). Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: a case study. Frontiers in Psychology, 6, 967-1-967-6. DOI Scopus14 WoS11 Europe PMC6 |
2015 |
Posselt, M., Procter, N., de Crespigny, C., & Galletly, C. (2015). Merging perspectives: obstacles to recovery for youth from refugee backgrounds with comorbidity. Australasian Psychiatry, 23(3), 293-299. DOI Scopus14 WoS12 Europe PMC6 |
2015 |
Weickert, T., Weinberg, D., Lenroot, R., Catts, S., Wells, R., Vercammen, A., . . . Weickert, C. (2015). Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Molecular Psychiatry, 20(6), 685-694. DOI Scopus110 WoS96 Europe PMC61 |
2015 |
Happell, B., Platania-Phung, C., Webster, S., McKenna, B., Millar, F., Stanton, R., . . . Scott, D. (2015). Applying the World Health Organization Mental Health Action Plan to evaluate policy on addressing co-occurrence of physical and mental illnesses in Australia. Australian Health Review, 39(4), 370-378. DOI Scopus11 WoS11 Europe PMC7 |
2015 |
Kisely, S., Chang, A., Crowe, J., Galletly, C., Jenkins, P., Loi, S., . . . Macfarlane, S. (2015). Getting started in research: Systematic reviews and meta-analyses. Australasian Psychiatry, 23(1), 16-21. DOI Scopus6 Europe PMC2 |
2015 |
Lacey, M., Paolini, S., Hanlon, M., Melville, J., Galletly, C., & Campbell, L. (2015). Parents with serious mental illness: differences in internalised and externalised mental illness stigma and gender stigma between mothers and fathers. Psychiatry Research, 225(3), 723-733. DOI Scopus39 WoS33 Europe PMC16 |
2015 |
Clarke, P., Gill, S., Carnell, B., & Galletly, C. (2015). How safe is repetitive Transcranial Magnetic Stimulation?. Australian and New Zealand Journal of Psychiatry, 49(5), 485. DOI Scopus6 WoS5 Europe PMC2 |
2015 |
Ford, N., Ludbrook, G., & Galletly, C. (2015). Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. Australian and New Zealand Journal of Psychiatry, 49(12), 1227. DOI Scopus21 WoS15 Europe PMC11 |
2015 |
Suetani, S., Gill, S., & Galletly, C. (2015). A scholarly endeavour: Some practical tips on completing the scholarly project. Australasian Psychiatry, 23(1), 29-31. DOI Scopus10 WoS10 Europe PMC6 |
2015 |
Galletly, C. A., Loo, C. K., Malhi, G. S., Mitchell, P. B., & Fitzgerald, P. (2015). Why repetitive transcranial magnetic stimulation should be available for treatment resistant depression. Australian and New Zealand Journal of Psychiatry, 49(2), 182-183. DOI Scopus1 WoS1 |
2015 |
Nenke, M., Hahn, L., Thompson, C., Liu, D., & Galletly, C. (2015). Psychosis and cardiovascular disease: Is diet the missing link?. Schizophrenia Research, 161(2-3), 465-470. DOI Scopus17 WoS15 Europe PMC10 |
2015 |
Foley, D., Mackinnon, A., Morgan, V., Watts, G., Shaw, J., Magliano, D., . . . Galletly, C. (2015). Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sample. The Australian and New Zealand Journal of Psychiatry, 49(8), 714-723. DOI Scopus11 WoS8 Europe PMC6 |
2015 |
Cairney, I., Galletly, C., de Crespigny, C., Liu, D., Moss, J., & Procter, N. (2015). Stopping the run-around? A study of services for people with comorbid mental health and substance use disorders in northern Adelaide. Australasian Psychiatry, 23(3), 233-235. DOI Scopus2 WoS2 Europe PMC1 |
2015 |
Posselt, M., Procter, N., Galletly, C., & de Crespigny, C. (2015). Aetiology of coexisting mental health and alcohol and other drug disorders: perspectives of refugee youth and service providers. Australian Psychologist, 50(2), 130-140. DOI Scopus24 WoS20 |
2015 |
Galletly, C. (2015). Let there be light .... Australian and New Zealand Journal of Psychiatry, 49(3), 201-202. DOI |
2015 |
Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2015). Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study. The Lancet Psychiatry, 2(12), 1092-1098. DOI Scopus26 WoS22 Europe PMC9 |
2015 |
Galletly, C. A. (2015). Making things better?. Australian and New Zealand Journal of Psychiatry, 49(11), 958-959. DOI |
2015 |
Galletly, C., Clarke, P., Carnell, B., & Gill, S. (2015). A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on. Australian and New Zealand Journal of Psychiatry, 49(11), 1040-1047. DOI Scopus17 WoS10 Europe PMC5 |
2015 |
Badcock, J., Shah, S., Mackinnon, A., Stain, H., Galletly, C., Jablensky, J., & Morgan, V. (2015). Loneliness in psychotic disorders and its association with cognitive function and symptom profile. Schizophrenia Research, 169(1-3), 268-273. DOI Scopus112 WoS90 Europe PMC59 |
2015 |
Galletly, C. A. (2015). ANZJP Weltanschauung. Australian and New Zealand Journal of Psychiatry, 49(8), 677-678. DOI |
2015 |
de Crespigny, C., Groenkjaer, M., Liu, D., Moss, J., Cairney, I., Procter, N., . . . Galletly, C. (2015). Service provider barriers to treatment and care for people with mental health and alcohol and other drug comorbidity in a metropolitan region of South Australia. Advances in Dual Diagnosis, 8(3), 120-128. DOI Scopus13 WoS14 |
2015 |
Sweeney, S., Air, T., Zannettino, L., & Galletly, C. (2015). Psychosis, socioeconomic disadvantage, and health service use in South Australia: Findings from the second. Frontiers in Public Health, 3, 1-8. DOI Scopus28 Europe PMC14 |
2015 |
Sweeney, S., Air, T., Zannettino, L., & Galletly, C. (2015). Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis. Frontiers in Psychology, 6(NOV), 1768-1-1768-8. DOI Scopus35 WoS31 Europe PMC19 |
2014 |
Gill, S., Clarke, P., Rigby, A., Carnell, B., & Galletly, C. (2014). Transcranial Magnetic Stimulation and psychological therapies: Considering the benefits of a combined treatment approach for depression. World Journal of Medical Research, 3(7), 46-53. |
2014 |
Galletly, C. A. (2014). Educating psychiatrists in the post-pharma era. Andhra Pradesh Journal of Psychological Medicine, 15(1), 10-12. |
2014 |
Shah, S., Mackinnon, A., Galletly, C., Carr, V., McGrath, J., Stain, H., . . . Morgan, V. (2014). Prevalence and impact of childhood abuse in people with a psychotic illness. Data from the second Australian national survey of psychosis. Schizophrenia Research, 159(1), 20-26. DOI Scopus29 WoS26 Europe PMC18 |
2014 |
Morgan, V., McGrath, J., Jablensky, A., Badcock, J., Waterreus, A., Bush, R., . . . MacKinnon, A. (2014). Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychological Medicine, 44(10), 2163-2176. DOI Scopus152 WoS150 Europe PMC90 |
2014 |
Hahn, L., Galletly, C., Foley, D., Mackinnon, A., Watts, G., Castle, D., . . . Morgan, V. (2014). Inadequate fruit and vegetable intake in people with psychosis. Australian and New Zealand Journal of Psychiatry, 48(11), 1025-1035. DOI Scopus38 WoS34 Europe PMC24 |
2014 |
Chan, W., Batterham, P., Christensen, H., & Galletly, C. (2014). Suicide literacy, suicide stigma and help-seeking intentions in Australian medical students. Australasian Psychiatry, 22(2), 132-139. DOI Scopus75 WoS59 Europe PMC42 |
2014 |
Balzan, R. P., Neaves, A., Denson, L. A., Liu, D., & Galletly, C. (2014). Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?. Cognitive Neuropsychiatry, 19(6), 471-484. DOI Scopus23 WoS23 Europe PMC17 |
2014 |
Searle, A., Baghurst, P., van Hooff, M., Sawyer, M., Sim, M., Galletly, C., . . . McFarlane, A. (2014). Tracing the long-term legacy of childhood lead exposure: a review of three decades of the Port Pirie Cohort study. NeuroToxicology, 43, 46-56. DOI Scopus45 WoS33 Europe PMC24 |
2014 |
Foley, D., MacKinnon, A., Morgan, V., Watts, G., McGrath, J., Castle, D., . . . Galletly, C. (2014). Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis. World Psychiatry, 13(2), 176-183. DOI Scopus27 WoS27 Europe PMC20 |
2014 |
Galletly, C., Clarke, P., Paterson, T., Rigby, A., & Gill, S. (2014). Practical considerations in the use of ultrabrief ECT in clinical practice. Journal of ECT, 30(1), 10-14. DOI Scopus20 WoS16 Europe PMC11 |
2014 |
Posselt, M., Galletly, C., de Crespigny, C., Cairney, I., Moss, J., Liu, D., . . . Banders, A. (2014). Ethics overload: impact of excessive ethical review on comorbidity research. Mental Health and Substance Use, 7(3), 184-194. DOI Scopus6 |
2014 |
Posselt, M., Galletly, C., de Crespigny, C., & Procter, N. (2014). Mental health and drug and alcohol comorbidity in young people of refugee background: a review of the literature. Mental Health and Substance Use, 7(1), 19-30. DOI Scopus29 |
2014 |
Galletly, C. (2014). Should lithium be added to the drinking water?. Australian & New Zealand Journal of Psychiatry, 48(9), 793-794. DOI |
2014 |
Ashton, M., Rigby, A., & Galletly, C. (2014). Do population-wide tobacco control approaches help smokers with mental illness?. Australian & New Zealand Journal of Psychiatry, 48(2), 121-123. DOI Scopus14 WoS12 Europe PMC7 |
2014 |
Burton, C., Gill, S., Clarke, P., & Galletly, C. (2014). Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report. Archives of Women's Mental Health, 17(3), 247-250. DOI Scopus14 WoS12 Europe PMC3 |
2014 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2014). Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single module programme. Australian and New Zealand Journal of Psychiatry, 48(12), 1126-1136. DOI Scopus51 WoS45 Europe PMC27 |
2014 |
Hahn, L., Rigby, A., & Galletly, C. (2014). Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia. Australian and New Zealand Journal of Psychiatry, 48(1), 70-79. DOI Scopus20 WoS19 Europe PMC15 |
2013 |
Galletly, C. (2013). When the body attacks the brain. Australian and New Zealand Journal of Psychiatry, 47(12), 1099-1100. DOI |
2013 |
Tidswell, J., Kleinig, T., Ash, D., Thompson, P., & Galletly, C. (2013). Early recognition of anti-N-methyl D-aspartate (Nmda) receptor encephalitis presenting as acute psychosis. Australasian Psychiatry, 21(6), 596-599. DOI Scopus12 WoS10 Europe PMC8 |
2013 |
Galletly, C., & Rigby, A. (2013). An overview of cognitive remediation therapy for people with severe mental illness. ISRN Rehabilitation, 2013, 1-6. DOI |
2013 |
McFarlane, A., Searle, A., Van Hooff, M., Baghurst, P., Sawyer, M., Galletly, C., . . . Clark, L. (2013). Prospective associations between childhood low-level lead exposure and adult mental health problems: The port pirie cohort study. Neurotoxicology, 39, 11-17. DOI Scopus29 WoS29 Europe PMC15 |
2013 |
Galletly, C. (2013). Sunshine, supplements, CBT and more. Australian and New Zealand Journal of Psychiatry, 47(3), 199-200. DOI |
2013 |
Altree, T., & Galletly, C. (2013). Laxative use and altered drug absorption. Australian and New Zealand Journal of Psychiatry, 47(7), 686. DOI Scopus3 WoS2 |
2013 |
Ashton, M., Rigby, A., & Galletly, C. (2013). What do 1000 smokers with mental illness say about their tobacco use?. Australian and New Zealand Journal of Psychiatry, 47(7), 631-636. DOI Scopus30 WoS26 Europe PMC21 |
2013 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2013). Illusory correlations and control across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches. Journal of Nervous and Mental Disease, 201(4), 319-327. DOI Scopus24 WoS22 Europe PMC15 |
2013 |
Ashton, M., Mulconray, S., Weston, M., Rigby, A., & Galletly, C. (2013). Peer workers' role in smoking-cessation groups for people with mental illness. Australasian Psychiatry, 21(3), 246-248. DOI Scopus4 WoS6 Europe PMC5 |
2013 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2013). Confirmation biases across the psychosis continuum: The contribution of hypersalient evidence-hypothesis matches. British Journal of Clinical Psychology, 52(1), 53-69. DOI Scopus53 WoS49 Europe PMC28 |
2013 |
Ashton, M., Rigby, A., & Galletly, C. (2013). Evaluation of a community-based smoking cessation programme for people with severe mental illness. Tobacco Control, 24(3), 275-280. DOI Scopus21 WoS19 Europe PMC12 |
2013 |
Foley, D., Mackinnon, A., Watts, G., Shaw, J., Magliano, D., Castle, D., . . . Galletly, C. (2013). Cardiometabolic risk Indicators that distinguish adults with psychosis from the general population, by age and gender. PLoS One, 8(12), 1-8. DOI Scopus38 WoS37 Europe PMC26 |
2012 |
Hall, T., Galletly, C., Clark, C., Veltmeyer, M., Metzger, L., Gilbertson, M., . . . McFarlane, A. (2012). The relationship between Hippocampal asymmetry and working memory processing in combat-related PTSD: a monozygotic twin study. Biology of Mood & Anxiety Disorders, 2(21), 1-8. DOI Europe PMC5 |
2012 |
Galletly, C., Neaves, A., Burton, C., Liu, D., & Denson, L. (2012). Evaluating health literacy in people with mental illness using the Test of Functional Health Literacy in Adults. Nursing Outlook, 60(5), 316-321. DOI Scopus20 WoS19 Europe PMC8 |
2012 |
Campbell, L., Hanlon, M., Poon, A., Paolini, S., Stone, M., Galletly, C., . . . Cohen, M. (2012). The experiences of Australian parents with psychosis: the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 890-900. DOI Scopus59 WoS47 Europe PMC29 |
2012 |
Stain, H., Galletly, C., Clark, S., Wilson, J., Killen, E., Anthes, L., . . . Harvey, C. (2012). Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 879-889. DOI Scopus127 WoS94 Europe PMC66 |
2012 |
Moore, E., Mancuso, S., Slade, T., Galletly, C., & Castle, D. (2012). The impact of alcohol and illicit drugs on people with psychosis: the Second Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 864-878. DOI Scopus61 WoS52 Europe PMC35 |
2012 |
Cooper, J., Mancuso, S., Borland, R., Slade, T., Galletly, C., & Castle, D. (2012). Tobacco smoking among people living with a psychotic illness: the second Australian survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 851-863. DOI Scopus139 WoS121 Europe PMC93 |
2012 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2012). Reasoning heuristics across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches. Cognitive Neuropsychiatry, 17(5), 431-450. DOI Scopus28 WoS26 Europe PMC16 |
2012 |
Waterreus, A., Morgan, V., Castle, D., Galletly, C., Jablensky, A., Di Prinzio, P., & Shah, S. (2012). Medication for psychosis - consumption and consequences: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 762-773. DOI Scopus48 WoS45 Europe PMC28 |
2012 |
Galletly, C., Foley, D., Waterreus, A., Watts, G., Castle, D., McGrath, J., . . . Morgan, V. (2012). Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 753-761. DOI Scopus164 WoS152 Europe PMC105 |
2012 |
Waghorn, G., Saha, S., Harvey, C., Morgan, V., Waterreus, A., Bush, R., . . . McGrath, J. (2012). 'Earning and learning' in those with psychotic disorders: the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 774-785. DOI Scopus100 WoS92 Europe PMC57 |
2012 |
Morgan, V., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J., Carr, V., . . . Saw, S. (2012). People living with psychotic illness in 2010: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 735-752. DOI Scopus399 WoS321 Europe PMC245 |
2012 |
Ash, D., Singh, T., Air, T., Burton, C., & Galletly, C. (2012). Metabolic health of people admitted to a psychiatric intensive care unit in Adelaide, South Australia. Primary Care Companion to the Journal of Clinical Psychiatry, 14(1), 1-2. DOI |
2012 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2012). Over-adjustment or miscomprehension? A re-examination of the jumping to conclusions bias. Australian and New Zealand Journal of Psychiatry, 46(6), 532-540. DOI Scopus62 WoS61 Europe PMC34 |
2012 |
Balzan, R., Delfabbro, P., & Galletly, C. (2012). Delusion-proneness or miscomprehension? A re-examination of the jumping-to-conclusions bias. Australian Journal of Psychology, 64(2), 100-107. DOI Scopus18 WoS20 |
2012 |
Kelly, D., Gill, S., Clarke, P., Burton, C., & Galletly, C. (2012). Delayed response to repetitive transcranial magnetic stimulation treatment for intractable auditory hallucinations in schizoaffective disorder. Annals of Clinical Psychiatry, 24(2), 172-173. Scopus3 WoS1 Europe PMC1 |
2012 |
Forbes, F., Galletly, C., Liu, D., Tyllis, P., & Clark, C. (2012). Assessing cognition in schizophrenia: a comparison of clinician and computerized test administration. Applied Neuropsychology, 19(0001), 9-15. DOI Scopus3 WoS2 Europe PMC2 |
2012 |
Galletly, C., Paterson, T., & Burton, C. (2012). A report on the introduction of ultrabrief pulse width ECT in a private psychiatric hospital. Journal of ECT, 28(1), 59. DOI Scopus11 WoS10 Europe PMC2 |
2012 |
Galletly, C., Gill, S., Clarke, P., Burton, C., & Fitzgerald, P. (2012). A randomized trial comparing repetitive transcranial magnetic stimulation given 3 days/week and 5 days/week for the treatment of major depression: Is efficacy related to the duration of treatment or the number of treatments?. Psychological Medicine, 42(5), 981-988. DOI Scopus42 WoS34 Europe PMC29 |
2012 |
Galletly, C. (2012). Debates, disputes, discussions and deliberations. Australian and New Zealand Journal of Psychiatry, 46(10), 917-918. DOI |
2012 |
Dawson, S., Kettler, L., Burton, C., & Galletly, C. (2012). Do people with schizophrenia lack emotional intelligence?. Schizophrenia Research and Treatment, Online, 1-8. DOI Europe PMC6 |
2012 |
Silverstein, S., All, S., Thompson, J., Williams, L., Whitford, T., Nagy, M., . . . Gordon, E. (2012). Absolute level of gamma synchrony is increased in first-episode schizophrenia during face processing. Journal of Experimental Psychopathology, 3(4), 702-723. DOI Scopus5 WoS4 |
2012 |
Galletly, C. (2012). People living with psychosis: the good news and the bad news. Australian and New Zealand Journal of Psychiatry, 46(9), 803-807. DOI Scopus6 WoS4 Europe PMC4 |
2012 |
Galletly, C., Clark, L., Van Hooff, M., & McFarlane, A. (2012). CHILDHOOD TRAUMA AND SUBCLINICAL PSYCHOTIC EXPERIENCES IN YOUNG ADULTHOOD: 20-YEAR LONGITUDINAL ANALYSES OF TWO COHORT STUDIES. SCHIZOPHRENIA RESEARCH, 136, S63-S64. DOI WoS1 |
2012 |
Galletly, C. A., de Crespigny, C., Athanasos, P., Moss, J., Proctor, N., Banders, A., . . . Francis, H. (2012). COMORBIDITY ACTION RESEARCH IN NORTHERN ADELAIDE, SOUTH AUSTRALIA. SCHIZOPHRENIA RESEARCH, 136, S276. DOI |
2012 |
Galletly, C. A., Foley, D. L., Waterreus, A., Watts, G. F., Castle, D., McGrath, J., . . . Morgan, V. A. (2012). HIGH RATES OF CARDIOMETABOLIC RISK FACTORS IN PEOPLE WITH PSYCHOTIC DISORDERS. SCHIZOPHRENIA RESEARCH, 136, S308. DOI |
2011 |
Galletly, C. A. (2011). Differential diagnosis of Tardive Dyskinesia in an elderly woman taking antipsychotic medication. Annals of Clinical Psychiatry, 23(4), 308-309. |
2011 |
Galletly, C., Van Hooff, M., & McFarlane, A. (2011). PSYCHOTIC SYMPTOMS IN YOUNG ADULTS EXPOSED TO BUSHFIRES DURING CHILDHOOD - A 20 YEAR FOLLOW-UP STUDY. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 45, A34. |
2011 |
Galletly, C., Van Hooff, M., & McFarlane, A. (2011). Psychotic symptoms in young adults exposed to childhood trauma - A 20 year follow-up study. Schizophrenia Research, 127(1-3), 76-82. DOI Scopus54 WoS51 Europe PMC31 |
2011 |
Galletly, C., Bell, S., Burton, C., & Turnbull, C. (2011). Bed accessibility in a private psychiatric hospital. Australasian Psychiatry, 19(2), 160-162. DOI Scopus2 WoS2 |
2011 |
Galletly, C., & Burton, C. (2011). Improving medical student attitudes towards people with schizophrenia. Australian and New Zealand Journal of Psychiatry, 45(6), 473-476. DOI Scopus53 WoS48 Europe PMC22 |
2011 |
Galletly, C. (2011). ANZJP This Month. Australian and New Zealand Journal of Psychiatry, 45(12), 1015-1016. DOI |
2011 |
Crismani, C., & Galletly, C. (2011). 'Walk-ins': Developing a nursing role to manage unscheduled presentations to a community mental health clinic. Contemporary Nurse, 39(1), 12-19. DOI Scopus2 WoS2 Europe PMC1 |
2011 |
Galletly, C., & Crichton, J. (2011). Accomplishments of the thought disordered person: A case study in psychiatrist-patient interaction. Medical Hypotheses, 77(5), 900-904. DOI Scopus3 WoS3 Europe PMC1 |
2010 |
Singh, R., Rowan, J., Burton, C., & Galletly, C. (2010). How effective is a hospital at home service for people with acute mental illness?. Australasian Psychiatry, 18(6), 512-516. DOI Scopus12 WoS13 Europe PMC5 |
2010 |
Galletly, C., Fitzgerald, P., Clarke, P., Gill, S., Burton, C., & Turnbull, C. (2010). A practical guide to setting up a repetitive transcranial magnetic stimulation (rTMS) service. Australasian Psychiatry, 18(4), 314-317. DOI Scopus6 WoS6 Europe PMC5 |
2010 |
Galletly, C. A. (2010). Ask patients about their internet use. Medical Journal of Australia, 193(5), 312. DOI Scopus2 WoS1 Europe PMC1 |
2009 |
Ash, D., & Galletly, C. (2009). Challenges in psychiatric classification: The case of generalized anxiety disorder. Australasian Psychiatry, 17(6), 484-487. DOI Scopus1 |
2009 |
Galletly, C., Chur-Hansen, A., Air, T., & Chapman, I. (2009). Academics of the future? A survey of final year medical students. Australasian Psychiatry, 17(6), 502-505. DOI Scopus9 WoS7 Europe PMC5 |
2009 |
Harvey, K., Galletly, C., Field, C., & Proeve, M. (2009). The effects of verbalisation on cognitive performance in schizophrenia: A pilot study using tasks from Delis Kaplan Executive Function System. Neuropsychological Rehabilitation, 19(5), 733-741. DOI Scopus10 WoS7 Europe PMC5 |
2009 |
Alexander, D., Flynn, G., Wong, W., Whitford, T., Harris, A., Galletly, C., & Silverstein, S. (2009). Spatio-temporal EEG waves in first episode schizophrenia. Clinical Neurophysiology, 120(9), 1667-1682. DOI Scopus21 WoS18 Europe PMC17 |
2009 |
Clark, C., Galletly, C., Ash, D., Moores, K., Penrose, R., & McFarlane, A. (2009). Evidence-based medicine evaluation of electrophysiological studies of the anxiety disorders. Clinical EEG and Neuroscience, 40(2), 84-112. DOI Scopus55 WoS43 Europe PMC27 |
2009 |
Galletly, C. (2009). Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology, 202(1-3), 259-273. DOI Scopus42 WoS30 Europe PMC22 |
2009 |
Galletly, C., & Burton, C. (2009). The effects of experiencing simulated auditory hallucinations on attitudes to schizophrenia in final year medical students. Proceedings of 2nd Biennial Schizophrenia International Research Conference, 117(2-3), 402-403. DOI WoS1 |
2008 |
Flynn, G., Alexander, D., Harris, A., Whitford, T., Wong, W., Galletly, C., . . . Williams, L. (2008). Increased absolute magnitude of gamma synchrony in first-episode psychosis. Schizophrenia Research, 105(1-3), 262-271. DOI Scopus63 WoS57 Europe PMC37 |
2008 |
Nestor, P., & Galletly, C. (2008). The employment of consumers in mental health services: politically correct tokenism or genuinely useful?. Australasian Psychiatry, 16(5), 344-347. DOI Scopus29 WoS26 Europe PMC18 |
2008 |
Savilla, K., Kettler, L., & Galletly, C. (2008). Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Australian and New Zealand Journal of Psychiatry, 42(6), 496-504. DOI Scopus90 WoS72 Europe PMC49 |
2008 |
Galletly, C., McFarlane, A., & Clark, C. (2008). Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder. Psychiatry Research, 159(1-2), 196-206. DOI Scopus8 WoS9 Europe PMC9 |
2008 |
Williams, L., Whitford, T., Flynn, G., Wong, W., Liddell, B., Silverstein, S., . . . Gordon, E. (2008). General and social cognition in first episode schizophrenia: Identification of separable factors and prediction of functional outcome using the IntegNeuro, test battery. Schizophrenia Research, 99(1-3), 182-191. DOI Scopus94 WoS79 Europe PMC56 |
2008 |
Edwards, B., Galletly, C., Semmler-Booth, T., & Dekker, G. (2008). Does antenatal screening for psychosocial risk factors predict postnatal depression? A follow-up study of 154 women in Adelaide, South Australia. Australian and New Zealand Journal of Psychiatry, 42(1), 51-55. DOI Scopus46 WoS40 Europe PMC31 |
2008 |
Edwards, B., Galletly, C., Semmler-Booth, T., & Dekker, G. (2008). Antenatal psychosocial risk factors and depression amoung women living in socioeconomically disadvantaged suburbs in Adelaide, South Australia. Australian and New Zealand Journal of Psychiatry, 42(1), 45-50. DOI Scopus47 WoS43 Europe PMC36 |
2008 |
Keks, N., Galletly, C. A., Hope, J., & Hustig, H. (2008). Management of acute psychosis in an emergency setting. Advances in Schizophrenia and Clinical Psychiatry, 3, 78`-83. |
2007 |
Galletly, C. A., McFarlane, A. C., & Clark, C. R. (2007). Erratum to "Impaired updating of working memory in schizophrenia" [International Journal of Psychophysiology 63 (2007) 265-274] (DOI:10.1016/j.ijpsycho.2006.11.004). International Journal of Psychophysiology, 66(3), 271. DOI |
2007 |
Plevin, D., Galletly, C., & Roughan, P. (2007). Sexual dysfunction in men treated with depot antipsychotic drugs: A pilot study. Sexual Health, 4(4), 269-271. DOI Scopus6 WoS6 Europe PMC3 |
2007 |
Galletly, C., Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2007). Psychological benefits of a high-protein low-carbohydrate diet in obese women with polycystic ovary syndrome - A pilot study. Appetite, 49(3), 590-593. DOI Scopus75 WoS59 Europe PMC45 |
2007 |
Galletly, C., McFarlane, A., & Clark, C. (2007). Impaired updating of working memory in schizophrenia. International Journal of Psychophysiology, 63(3), 265-274. DOI Scopus25 WoS20 Europe PMC14 |
2006 |
Galletly, C., & Watson, D. (2006). Substance misuse in patients with acute mental illness. Medical Journal of Australia, 184(12), 645. DOI Scopus1 WoS1 Europe PMC1 |
2006 |
Brown, K., Alexander, D., Boord, P., Das, P., Flynn, G., Galletly, C., . . . Williams, L. (2006). Reduced fMRI activity in response to salient stimuli in first-episode schizophrenia.. Acta neuropsychiatrica, 18(6), 279-280. DOI |
2006 |
Galletly, C., Proeve, M., Field, C., & Harvey, K. (2006). Silence is golden? Improving cognitive performance in schizophrenia.. Acta neuropsychiatrica, 18(6), 251. DOI |
2006 |
Das, P., Alexander, D., Boord, P., Brown, K., Flynn, G., Galletly, C., . . . Wong, W. (2006). Impaired connectivity in amygdala pathways may explain disorganization symptoms of patients with first-episode schizophrenia.. Acta neuropsychiatrica, 18(6), 282. DOI Europe PMC1 |
2006 |
Alexander, D., Boord, P., Brown, K., Das, P., Flynn, G., Galletly, C., . . . Wong, W. (2006). First-episode psychosis and direction of wave propagation at 1 Hz in the EEG.. Acta neuropsychiatrica, 18(6), 240. DOI Europe PMC1 |
2005 |
Galletly, C., Clark, C., & McFarlane, A. (2005). Clozapine improves working memory updating in schizophrenia. European Neuropsychopharmacology, 15(6), 601-608. DOI Scopus16 WoS15 Europe PMC10 |
2004 |
Galletly, C. (2004). Crossing professional boundaries in medicine: the slippery slope to patient sexual exploitation. Medical Journal of Australia, 181(7), 380-383. DOI Scopus55 WoS43 Europe PMC19 |
2004 |
Moran, L., Noakes, M., Clifton, P., Wittert, G., Tomlinson, L., Galletly, C., . . . Norman, R. (2004). Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. Journal of Clinical Endocrinology and Metabolism, 89(7), 3337-3344. DOI Scopus148 WoS111 Europe PMC85 |
2004 |
Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., Galletly, C., & Norman, R. J. (2004). Erratum: Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome (Journal of Clinical Endocrinology and Metabolism (2003) 88 (812-819)). Journal of Clinical Endocrinology and Metabolism, 89(5), 2337. |
2003 |
Ash, D., Galletly, C., Haynes, J., & Braben, P. (2003). Violence, self-harm, victimisation and homelessness in patients admitted to an acute inpatient unit in South Australia. International Journal of Social Psychiatry, 49(2), 112-118. DOI Scopus18 Europe PMC12 |
2003 |
Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2003). Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88(2), 812-819. DOI Scopus422 WoS331 Europe PMC228 |
2001 |
Galletly, C., Clark, C., McFarlane, A., & Weber, D. (2001). Working memory in posttraumatic stress disorder - An event-related potential study. Journal of Traumatic Stress, 14(2), 295-309. DOI Scopus67 WoS59 Europe PMC45 |
2000 |
Comley, C., Galletly, C., & Ash, D. (2000). The use of atropine eye drops for clozapine induced hypersalivation. Australian and New Zealand Journal of Psychiatry, 34(6), 1033-1034. DOI |
2000 |
Galletly, C. (2000). Psychiatry and fertility services. Australasian Psychiatry, 8(3), 264-266. |
2000 |
Galletly, C., Clark, C., & McFarlane, A. (2000). Treating cognitive dysfunction in patients with schizophrenia. Journal of Psychiatry & Neuroscience, 25(2), 117-124. Scopus19 WoS19 Europe PMC12 |
2000 |
Galletly, C. A., Clark, C. R., McFarlane, A. C., & Weber, D. L. (2000). The effect of clozapine on the speed and accuracy of information processing in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 24(8), 1329-1338. DOI Scopus25 WoS23 Europe PMC13 |
2000 |
Galletly, C. (2000). Correspondence. Australasian Psychiatry, 8(3), 264-265. DOI |
2000 |
Comley, C., Galletly, C., & Ash, D. (2000). Use of atropine eye drops for clozapine induced hypersalivation [5]. Australian and New Zealand Journal of Psychiatry, 34(6), 1033-1034. DOI Scopus42 Europe PMC19 |
1999 |
Galletly, C. (1999). Prescribing of psychotropic drugs in an acute inpatient unit. Australian and New Zealand Journal of Psychiatry, 33(2), 181-182. DOI Scopus5 Europe PMC3 |
1999 |
Galletly, C., Clark, C., McFarlane, A., & Weber, D. (1999). Effects of Clozapine for Non-Treatment-Resistant Patients with Schizophrenia. Psychiatric Services, 50(1), 101-103. DOI Scopus15 WoS12 Europe PMC11 |
1999 |
Ash, D., Galletly, C., Kinneally, J., & Braben, P. (1999). Self-Reported Forensic Histories Among Patients Admitted to an Acute Psychiatric Unit. Psychiatry, Psychology and Law, 6(2), 197-202. DOI Scopus1 |
1998 |
Clark, A., Thornley, B., Tomlinson, L., Galletly, C., & Norman, R. (1998). Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction, 13(6), 1502-1505. DOI Scopus603 WoS463 Europe PMC286 |
1998 |
Galletly, C., & Whyte, F. (1998). Epidemiology of prostate cancer in two European countries: Scotland and Norway. European Journal of Cancer Care, 7(4), 240-246. DOI |
1997 |
Galletly, C. (1997). Borderline-dissociation comorbidity [8]. American Journal of Psychiatry, 154(11), 1629. DOI Scopus7 Europe PMC1 |
1997 |
Galletly, C. A., & Tsourtos, G. (1997). Antipsychotic drug doses and adjunctive drugs in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry, 9(2), 77-80. DOI Scopus12 Europe PMC9 |
1997 |
Galletly, C. A. (1997). Dissociation and PTSD. American Journal of Psychiatry, 154, 1629. |
1997 |
Field, C., Galletly, C., Anderson, D., & Walker, P. (1997). Computer aided cognitive rehabilitation possible application to the attentional deficit of schizophrenia, a report of negative results. Perceptual and Motor Skills, 85(3, part 1), 995-1002. DOI Scopus31 Europe PMC13 |
1997 |
Galletly, C., Clark, R., McFarlane, A., & Lueber, D. (1997). Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine.. Psychiatry Research, 72, 159-161. |
1997 |
Galletly, C. (1997). Clinical rating scales for substance abuse. Psychiatric Services, 48(1), 105-106. DOI |
1997 |
Galletly, C., & Tsourtos, G. (1997). Antipsychotic drug doses in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry, 9(2), 77-80. DOI |
1997 |
Galletly, C. (1997). Borderline-Dissociation Comorbidity. American Journal of Psychiatry, 154, 629. |
1997 |
Ash, D., & Galletly, C. (1997). Crisis beds: The interface between the hospital and the community. International Journal of Social Psychiatry, 43(3), 193-198. DOI Scopus8 Europe PMC1 |
1997 |
Galletly, C. A., Clark, C. R., McFarlane, A. C., & Weber, D. L. (1997). Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Research, 72(3), 161-166. DOI Scopus108 WoS90 Europe PMC61 |
1996 |
Galletly, C. A., Clark, C. R., & McFarlane, A. C. (1996). Artificial neural networks and psychiatric disorders. BRITISH JOURNAL OF PSYCHIATRY, 169(6), 793-794. DOI WoS1 |
1996 |
118. McFarlane, A. C., Clark, C. R., Weber, D., & Galletly, C. A. (1996). Biological paradigms of the attentional processing in post traumatic stress disorder. European Neuropsychopharmacology, 6, 80. |
1996 |
Galletly, C., Clark, A., & Tomlinson, L. (1996). Evaluation of dexfenfluramine in a weight loss program for obese infertile women.. International Journal of Eating Disorders, 19(2), 209-212. DOI Scopus11 Europe PMC5 |
1996 |
Galletly, C., Clark, A., Tomlinson, L., & Blaney, F. (1996). Improved pregnancy rates for obese, infertile women following a group treatment program: an open pilot study. General Hospital Psychiatry, 18(3), 192-195. DOI Scopus50 Europe PMC21 |
1996 |
Galletly, C. (1996). Comment on "Sexual Abuse in therapy : gender issues.". Australian and New Zealand Journal of Psychiatry, 30, 132-133. |
1996 |
Galletly, C. (1996). Subjective muscle weakness and hypotnoia during Clozapine treatment. Annals of Clinical Psychiatry, 8(4), 189-192. DOI Scopus6 Europe PMC6 |
1996 |
Galletly, C., Clark, A., Tomlinson, L., & Blaney, F. (1996). A group program for obese, infertile women: weight loss and improved psychological health. Journal of Psychosomatic Obstetrics and Gynaecology, 17(2), 125-128. DOI Scopus37 Europe PMC20 |
1996 |
Galletly, C., Clark, C., & McFarlane, A. (1996). Artificial Neural Networks: A prospective tool for the analysis of psychiatric disorders.. Journal of Psychiatry and Neuroscience, 21(4), 239-247. Scopus14 WoS9 Europe PMC5 |
1996 |
Galletly, C., Wilson, D., & McEwen, S. (1996). Eosiniphilia associated with decreasing neutrophil count in a Clozapine-treated patient.. Journal of Clinical Psychiatry, 57, 40-41. Scopus4 Europe PMC3 |
1996 |
Galletly, C. A., Clark, C. R., & McFarlane, A. C. (1996). Artificial neural networks and psychiatric disorders.. The British journal of psychiatry : the journal of mental science, 169(6), 793-794. DOI Scopus1 |
1996 |
Galletly, C. (1996). Comment. Australian and New Zealand Journal of Psychiatry, 30(1), 132-133. DOI |
1995 |
Clark, A., Ledger, W., Galletly, C., Tomlinson, L., Blaney, F., Wang, X., & Norman, R. (1995). Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reproduction, 10(10), 2705-2712. DOI Scopus539 WoS389 Europe PMC229 |
1995 |
Galletly, C. A., Schrader, G. D., Chestemtan, H. M., & Tsourtos, G. (1995). Medical student attitudes to psychiatry: lack of effect of psychiatric hospital experience. Medical Education, 29(6), 449-451. DOI Scopus44 WoS34 Europe PMC20 |
1993 |
123. Burnett, P. L., Galletly, C. A., Moyle, R. J., & Clark, R. (1993). A review of the efficacy of low-dose antipsychotic medication in the treatment of schizophrenia. Schizophrenia Bulletin, 19, 155-164. |
1993 |
Burnett, P. L., Galletly, C. A., Moyle, R. J., & Clark, C. R. (1993). Low-dose depot medication in schizophrenia. Schizophrenia Bulletin, 19(1), 155-164. DOI Scopus15 WoS17 Europe PMC5 |
1993 |
Galletly, C. A. (1993). Psychiatrist-patient sexual relationships: The ethical dilemmas. Australasian Psychiatry, 27(1), 133-139. DOI Scopus17 WoS14 Europe PMC9 |
1993 |
Galletly, C. A., Field, C. D., & Prior, M. (1993). Urine drug screening of patients admitted to a state psychiatric hospital. Hospital and Community Psychiatry, 44(6), 587-589. DOI Scopus27 WoS24 Europe PMC11 |
1992 |
Galletly, C. A. (1992). Antipsychotic drug doses in a schizophrenia inpatient unit. Australian and New Zealand Journal of Psychiatry, 26(4), 574-576. DOI Scopus17 WoS14 Europe PMC8 |
1991 |
Galletly, C. A., Field, C. D., & Ormond, C. L. (1991). Changing patterns of electroconvulsive therapy use: Results of a five-year survey. Australian and New Zealand Journal of Psychiatry, 25(4), 535-540. DOI Scopus9 WoS9 Europe PMC4 |
1991 |
Galletly, C. A. (1991). A review of antipsychotic drug doses.. Australian clinical review / Australian Medical Association [and] the Australian Council on Hospital Standards, 11, 74-76. |
1987 |
Galletly, C. A., Field, C., & Ormond, C. (1987). An audit of electroconvulsive therapy.. Australian clinical review / Australian Medical Association [and] the Australian Council on Hospital Standards, 7(27), 171-174. Scopus1 Europe PMC1 |
1987 |
Galletly, C. A., & Field, C. D. (1987). Learning and memory impairment with benzhexol. Australian and New Zealand Journal of Psychiatry, 21(4), 612-614. DOI Scopus4 WoS5 Europe PMC2 |
1985 |
Galletly, C. A., Morris, H., & Newcombe, A. (1985). The dexamethasone suppression test in elderly, non-depressed patients with dementia. Australian and New Zealand Journal of Psychiatry, 19(1), 95-96. DOI Scopus3 WoS2 Europe PMC2 |
1983 |
131. Morris, H. A., Gilliland, J. M., Berriman, H. E., & Galletly, C. A. (1983). Assessment of the dexamethasone suppression test of endogenous depression. Clinical Biochemical Research, 4, 82. |
1982 |
Manley, D., & Galletly, C. A. (1982). Survey of children and their families presenting at a child psychiatric service. New Zealand Medical Journal, 95(718), 732-734. |
1982 |
James, B., & Galletly, C. A. (1982). The psychiatric contribution to general medical education: Some problems of generalization. Medical Education, 16(3), 147-150. DOI Scopus1 Europe PMC1 |
1979 |
Franzcp, B. J., & Galletly, C. A. (1979). Case notes as indicators of the prevailing medical model: Implications. New Zealand Medical Journal, 90(648), 427-431. |
1979 |
Galletly, C., & James, B. (1979). Anorexia nervosa in a male: Comment and illustration. New Zealand Medical Journal, 89(631), 171-173. Scopus2 Europe PMC1 |
- |
Galletly, C. (n.d.). Role of cognitive enhancement in schizophrenia. Neuroscience and Neuroeconomics, 75. DOI |